We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Gilead Resumes Direct Distribution of Remdesivir to Treat COVID-19
Gilead Resumes Direct Distribution of Remdesivir to Treat COVID-19
Gilead Sciences has resumed direct distribution to hospitals of its antiviral drug remdesivir, after HHS decided that the federal government no longer has to control the process because there is a sufficient supply to treat COVID-19 patients.